Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Richard Liebano
This study aimed to assess the effectiveness of interferential current (IFC) therapy in alleviating symptoms and improving functional outcomes in patients experiencing persistent non-specific low back pain. A randomized controlled trial was conducted involving participants aged [18-65] with a diagnosis of on-going non-specific low back pain. Participants were randomly assigned to either the IFC intervention group or a control group receiving standard care. The IFC group received, while the control group continued with their routine care, which included [describe standard care, e.g., medications, physical therapy]. Outcome measures included pain intensity, functional disability, and health-related quality of life, assessed at baseline, post-treatment, and follow-up intervals. The study demonstrated a significant reduction in pain intensity and functional disability in the IFC group compared to the control group (p < 0.05). Moreover, participants in the IFC group reported improvements in health-related quality of life at follow-up assessments. The intervention was well-tolerated, with no reported adverse effects. Interferential current therapy emerged as an effective adjunctive treatment for individuals with on-going nonspecific low back pain, contributing to pain reduction, improved functionality, and enhanced quality of life. These findings support the integration of IFC into comprehensive pain management strategies for individuals grappling with persistent low back pain. Further research exploring long-term effects and optimal treatment parameters is warranted to refine clinical recommendations.